Skip to content
2000
image of The Changing Face of HIV-Associated Malignancies: Is this the Same in Turkey As Well?

Abstract

Introduction

Cancers remain a major cause of mortality among individuals with HIV infection. This study aimed to determine the incidence, prevalence, and mortality of AIDS-defining cancers (ADCs) and non-AIDS-defining cancers (NADCs) in people living with HIV (PLWH).

Methods

This retrospective, cross-sectional study was conducted in Istanbul. Among patients diagnosed with HIV/AIDS between January 2011 and December 2019, those who developed cancer were analyzed. To assess changes in cancer types over time, the study period was divided into three-year intervals.

Results

Cancer was diagnosed in 57 (3.9%) of the 1,438 patients. The mean CD4 count was 272.3/mm3. Patients in the cancer group had significantly higher mean age at HIV diagnosis, higher HIV RNA levels, and lower CD4+ T lymphocyte counts. A notably high rate (72%) of simultaneous diagnosis of cancer and HIV was observed in the ADCs group. Kaposi sarcoma was identified in 23 (71.8%) patients, and non-Hodgkin lymphoma (NHL) in 9 patients. Hodgkin lymphoma and lung cancer were the most common cancers in the NADCs group.

Discussion

People living with HIV are experiencing longer life expectancy due to ART; however, this also increases cancer risk, emphasizing the need for national screening guidelines that consider age, gender, and immune status. A multidisciplinary approach is essential for effective prevention and treatment strategies. Since cancer risk is multifactorial, larger prospective and multicenter studies are needed to strengthen and expand these findings.

Conclusions

These findings highlight that AIDS-defining cancers continue to be a significant clinical concern in Turkey. Cancer screening should be integrated both at the time of HIV diagnosis and during routine follow-up of PLWH.

© 2026 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/chr/10.2174/011570162X392859251119055734
2026-01-22
2026-01-29

  • From This Site

    /content/journals/chr/10.2174/011570162X392859251119055734
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. World health data platform /GHO /Themes. 2025 Available from: https://www.who.int/data/gho/data/themes/HIV-aids
  2. Turkey Ministry of Health, Public Health Institution of Turkey, Department of Infectious Diseases HIV-AIDS statistics. 2025 Available from: https://hsgm.saglik.gov.tr/tr/bulasici-hastaliklar/HIV-aids/HIV-aids-liste/HIV-aids-istatislik.html
  3. Marques M. Luz E. Leal M. Oliveira J.V. Patrício R. Netto E.M. Brites C. Neoplasms-associated deaths in HIV-1 infected and non-infected patients in Bahia, Brazil. Cancer Epidemiol. 2018 54 133 136 10.1016/j.canep.2018.04.001 29727806
    [Google Scholar]
  4. Gheorghiță V. Conea I.F. Radu A.M.C. Ștefan I. Mărdărescu M. Petrea S. Streinu-Cercel A. Epidemiological trends and therapeutic challenges of malignancies in adult HIV-1-infected patients receiving combination antiretroviral therapy in a tertiary hospital from Romania: An observational retrospective study. J. Infect. Public Health 2019 12 2 182 189 10.1016/j.jiph.2018.09.011 30344102
    [Google Scholar]
  5. Levine A.M. AIDS-related malignancies: The emerging epidemic. J. Natl. Cancer Inst. 1993 85 17 1382 1397 10.1093/jnci/85.17.1382 8350362
    [Google Scholar]
  6. Cobucci R.N.O. Lima P.H. de Souza P.C. Costa V.V. Cornetta M.C.M. Fernandes J.V. Gonçalves A.K. Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: A systematic review. J. Infect. Public Health 2015 8 1 1 10 10.1016/j.jiph.2014.08.003 25294086
    [Google Scholar]
  7. Shmakova A. Germini D. Vassetzky Y. HIV‐1, HAART and cancer: A complex relationship. Int. J. Cancer 2020 146 10 2666 2679 10.1002/ijc.32730 31603989
    [Google Scholar]
  8. Vangipuram R. Tyring S.K. AIDS-Associated Malignancies. Cancer Treat. Res. 2019 177 1 21 10.1007/978‑3‑030‑03502‑0_1 30523619
    [Google Scholar]
  9. Mancuso P. Djuric O. Collini G. Serventi E. Massari M. Zerbini A. Giorgi Rossi P. Vicentini M. Risk of cancer in individuals with alcohol and drug use disorders: a registry-based study in Reggio Emilia, Italy. Eur. J. Cancer Prev. 2020 29 3 270 278 10.1097/CEJ.0000000000000553 32134400
    [Google Scholar]
  10. Spence A.B. Levy M.E. Monroe A. Castel A. Timpone J. Horberg M. Adams-Campbell L. Kumar P. Cancer incidence and cancer screening practices among a cohort of persons receiving HIV care in Washington, DC. J. Community Health 2020 10.1007/s10900‑020‑00844‑6 32424501
    [Google Scholar]
  11. Altuntas Aydin O. Gunduz A. Sargin F. Mete B. Karaosmanoglu H.K. Sevgi D.Y. Yemisen M. Durdu B. Dokmetas I. Tabak F. ACTHIV-IST (Action Against HIV in Istanbul) Study Group Prevalence and mortality of cancer among people living with HIV and AIDS patients: A large cohort study in Turkey. East. Mediterr. Health J. 2020 26 3 276 282 10.26719/emhj.19.030 32281636
    [Google Scholar]
  12. Shepherd L. Borges Á.H. Ledergerber B. Domingo P. Castagna A. Rockstroh J. Knysz B. Tomazic J. Karpov I. Kirk O. Lundgren J. Mocroft A. EuroSIDA in EuroCOORD Infection‐related and ‐unrelated malignancies, HIV and the aging population. HIV Med. 2016 17 8 590 600 10.1111/hiv.12359 26890156
    [Google Scholar]
  13. Silverberg M.J. Neuhaus J. Bower M. Gey D. Hatzakis A. Henry K. Hidalgo J. Lourtau L. Neaton J.D. Tambussi G. Abrams D.I. Risk of cancers during interrupted antiretroviral therapy in the SMART study. AIDS 2007 21 14 1957 1963 10.1097/QAD.0b013e3282ed6338 17721103
    [Google Scholar]
  14. Borges Á.H. Neuhaus J. Babiker A.G. Henry K. Jain M.K. Palfreeman A. Mugyenyi P. Domingo P. Hoffmann C. Read T.R.H. Pujari S. Meulbroek M. Johnson M. Wilkin T. Mitsuyasu R. INSIGHT START Study Group Immediate antiretroviral therapy reduces risk of infection-related cancer during early HIV infection. Clin. Infect. Dis. 2016 63 12 1668 1676 10.1093/cid/ciw621 27609756
    [Google Scholar]
  15. Castilho J.L. Bian A. Jenkins C.A. Shepherd B.E. Sigel K. Gill M.J. Kitahata M.M. Silverberg M.J. Mayor A.M. Coburn S.B. Wiley D. Achenbach C.J. Marconi V.C. Bosch R.J. Horberg M.A. Rabkin C.S. Napravnik S. Novak R.M. Mathews W.C. Thorne J.E. Sun J. Althoff K.N. Moore R.D. Sterling T.R. Sudenga S.L. Castilho J.L. Bian A. Jenkins C.A. Shepherd B.E. Sigel K. John Gill M. Kitahata M.M. Silverberg M.J. Mayor A.M. Coburn S.B. Wiley D. Achenbach C.J. Marconi V.C. Bosch R.J. Horberg M.A. Rabkin C.S. Napravnik S. Novak R.M. Christopher Mathews W. Thorne J.E. Sun J. Althoff K.N. Moore R.D. Sterling T.R. Sudenga S.L. North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiology Databases to Evaluate AIDS (IeDEA) CD4/CD8 ratio and cancer risk among adults with HIV. J. Natl. Cancer Inst. 2022 114 6 854 862 10.1093/jnci/djac053 35292820
    [Google Scholar]
  16. Malmström S. Wagner P. Yilmaz A. Svedhem V. Carlander C. Failure to restore CD4+ cell count associated with infection-related and noninfection-related cancer. AIDS 2022 36 3 447 457 10.1097/QAD.0000000000003117 34711738
    [Google Scholar]
  17. Ruffieux Y. Muchengeti M. Olago V. Dhokotera T. Bohlius J. Egger M. Rohner E. Age and cancer incidence in 5.2 million people with human immunodeficiency Virus (HIV): The South African HIV cancer match study. Clin. Infect. Dis. 2023 76 8 1440 1448 10.1093/cid/ciac925 36461916
    [Google Scholar]
  18. Yarchoan R. Uldrick T.S. HIV-Associated cancers and related diseases. N. Engl. J. Med. 2018 378 11 1029 1041 10.1056/NEJMra1615896 29539283
    [Google Scholar]
  19. Rihana N. Nanjappa S. Sullivan C. Velez A.P. Tienchai N. Greene J.N. Malignancy trends in HIV-infected patients over the past 10 years in a single-center retrospective observational study in the United States. Cancer Contr. 2018 25 1 1073274818797955 10.1177/1073274818797955 30185062
    [Google Scholar]
  20. Lee S. Lee S.H. Lee J.E. Kang J.S. Lee S.G. Chung J.S. Kwak I.S. Trends in malignancies among korean patients infected with human immunodeficiency virus in the highly active antiretroviral therapy era. J. Korean Med. Sci. 2017 32 9 1445 1450 10.3346/jkms.2017.32.9.1445 28776339
    [Google Scholar]
  21. Horner M.J. Chasimpha S. Spoerri A. Edwards J. Bohlius J. Tweya H. Tembo P. Nkhambule F. Phiri E.M. Miller W.C. Malisita K. Phiri S. Dzamalala C. Olshan A.F. Gopal S. High cancer burden among antiretroviral therapy users in Malawi: A record linkage study of observational human immunodeficiency virus cohorts and cancer registry data. Clin. Infect. Dis. 2019 69 5 829 835 10.1093/cid/ciy960 30452634
    [Google Scholar]
  22. European AIDS Clinical Society EACS guidelines (Version 6.1): Recommendations for initiation of antiretroviral therapy in HIV-positive persons without prior ART exposure. 2011 Available from: https://www.eacsociety.org/media/2011_eacsguidelines-v6.1-english_nov.pdf
  23. Turkish Ministry of Health, Public Health Institution of Turkey, Cancer Department Directorate Cancer screening, Ministry of Health cancer screening program. 2023 Available from: https://hsgm.saglik.gov.tr/tr/kanser-taramalari.html
  24. Republic of Turkey Ministry of Health, Public Health Institution of Turkey Turkey cancer statistics 2020. 2020 Available from: https://hsgm.saglik.gov.tr/tr/kanser-istatistikleri.html
  25. Turkish Thoracic Society Lung cancer, risk factors, smoking. 2025 Available from: https://toraks.org.tr/site/resources/aegrotationes/p/3
  26. Turkish Thoracic Society Consensus report on the diagnosis and treatment of tobacco products and nicotine addiction:Epidemiological data in Turkey. 2025 Available from: https://toraks.org.tr/site/sf/books
  27. Lurain K. Yarchoan R. Ramaswami R. The changing face of HIV-associated malignancies: Advances, opportunities, and future directions. Am Soc Clin Oncol Educ Book 2019 39 36 40 10.1200/EDBK_100017 31099683
    [Google Scholar]
  28. Bhikoo R. Allwood B. W. Irusen E. M. Koegelenberg C. F. N. Lung cancer presents at a younger age and is less likely to be curable in people living with HIV. Respiration 2024 103 1 47 50 10.1159/000534464 37879317
    [Google Scholar]
  29. da Silva Neto M. M. Brites C. Borges Á. H. Cancer during HIV infection. APMIS 2020 128 2 121 128 10.1111/apm.13020 31990100
    [Google Scholar]
  30. Rubinstein P. G. Aboulafia D. M. Zloza A. Malignancies in HIV/AIDS: From epidemiology to therapeutic challenges. AIDS 2014 28 4 453 465 10.1097/QAD.0000000000000071
    [Google Scholar]
  31. Suneja G. Shiels M.S. Angulo R. Copeland G.E. Gonsalves L. Hakenewerth A.M. Macomber K.E. Melville S.K. Engels E.A. Cancer treatment disparities in HIV-infected individuals in the United States. J. Clin. Oncol. 2014 32 22 2344 2350 10.1200/JCO.2013.54.8644 24982448
    [Google Scholar]
  32. Suneja G. Boyer M. Yehia B.R. Shiels M.S. Engels E.A. Bekelman J.E. Long J.A. Cancer treatment in patients with HIV infection and Non–AIDS-defining cancers: A survey of US oncologists. J. Oncol. Pract. 2015 11 3 e380 e387 10.1200/JOP.2014.002709 25873060
    [Google Scholar]
  33. Deeken J.F. Tjen-A-Looi A. Rudek M.A. Okuliar C. Young M. Little R.F. Dezube B.J. The rising challenge of non-AIDS-defining cancers in HIV-infected patients. Clin. Infect. Dis. 2012 55 9 1228 1235 10.1093/cid/cis613 22776851
    [Google Scholar]
  34. Souza T.F. Sym Y.V. Chehter E.Z. HIV and neoplasms: What do we know so far? Einstein (Sao Paulo) 2023 21 eRW0231 10.31744/einstein_journal/2023RW0231 37341221
    [Google Scholar]
  35. Zhang M. Yang R. Du Y. Feng H. Liu Y. Liu H. Wu D. Niu F. He P. Clinical characteristics, prognostic risk factors, and primary treatment for elderly patients with primary central nervous system lymphoma: A seer database-based research. Blood Lymphat. Cancer 2025 15 85 101 10.2147/BLCTT.S529249 40656512
    [Google Scholar]
  36. Horner M.J. Shiels M.S. Pfeiffer R.M. Engels E.A. Deaths attributable to cancer in the us human immunodeficiency virus population during 2001–2015. Clin. Infect. Dis. 2021 72 9 e224 e231 10.1093/cid/ciaa1016 32710777
    [Google Scholar]
/content/journals/chr/10.2174/011570162X392859251119055734
Loading
The Changing Face of HIV-Associated Malignancies: Is this the Same in Turkey As Well?
Bentham Science Publishers ; https://doi.org/10.2174/011570162X392859251119055734
/content/journals/chr/10.2174/011570162X392859251119055734
/content/journals/chr/10.2174/011570162X392859251119055734
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: HIV ; prevelance ; incidence ; mortality ; non-AIDS defining cancers ; AIDS defining cancers

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test